New York Medical College

NYMC Examines:

Kidney Disease

Nearly one in ten Americans or approximately 26 million people in the United States have chronic kidney disease (CKD) and millions of others are at increased risk. Today, kidney disease remains one of the top ten causes of death in this country.

Three Schools, Three Perspecitves


Chronic kidney disease and end-stage renal disease are growing threats to America’s health. The time is ripe for translational research—the transfer of discoveries made at the bench to treatment protocols at the patient’s bedside.

The Westchester Artificial Kidney Foundation and New York Medical College established the Renal Research Institute in 2002 to characterize the mechanisms of progression of kidney disease with the focus on endothelial dysfunction as a harbinger of atherosclerotic, diabetic and hypertensive vascular damage. Therapeutic options to curtail these abnormalities are being investigated by the team of faculty members, postdoctoral fellows, residents, graduate students and high-school students.

The Division of Nephrology of the Department of Medicine provides clinical care with a pathophysiological approach. Faculty members are also actively involved in clinical and basic science research, where they participate in NIH and industry sponsored research; studies involve chronic kidney disease, transplantation of new kidneys and dialysis disorders.